KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $2.8 billion.

  • Oscar Health's Cash & Equivalents rose 8165.12% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 8165.12%. This contributed to the annual value of $2.8 billion for FY2025, which is 8165.12% up from last year.
  • Oscar Health's Cash & Equivalents amounted to $2.8 billion in Q4 2025, which was up 8165.12% from $2.1 billion recorded in Q3 2025.
  • Oscar Health's 5-year Cash & Equivalents high stood at $2.8 billion for Q4 2025, and its period low was $1.1 billion during Q3 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.1 billion (2022), whereas its average is $1.9 billion.
  • Per our database at Business Quant, Oscar Health's Cash & Equivalents surged by 37208.36% in 2021 and then crashed by 3375.12% in 2023.
  • Over the past 5 years, Oscar Health's Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then surged by 41.18% to $1.6 billion in 2022, then increased by 20.0% to $1.9 billion in 2023, then decreased by 18.35% to $1.5 billion in 2024, then surged by 81.65% to $2.8 billion in 2025.
  • Its Cash & Equivalents was $2.8 billion in Q4 2025, compared to $2.1 billion in Q3 2025 and $2.6 billion in Q2 2025.